Patents/Assignees

ICM CO., Ltd.

1 patent in portfolio

US11628203utility2023
Pharmaceutical Composition for Treating Retinal Dystrophies, Comprising Nkx3.2 and Fragment Thereof as Active Ingredients
0 cites